Bizarre Patents
Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8153656 | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds Disclosed are beta and gamma-amino isoquinoline amide compounds and substituted benzamide compounds. In particular, the invention provides compounds that affect the function of kinases in a cell and that are useful as therapeutic agents or with therapeutic agents. T... | 04/10/2012 |
| 8143275 | Use of triazolopyrimidine derivatives as microbicides Use of compounds of the formula (I) in which R1, R2, R3 and R4 are as defined in the description for protecting engineered materials. ... | 03/27/2012 |
| 8133903 | Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases The present methods and compositions are of use for treatment of conditions involving fibrosis, such as Peyronie's disease plaque, penile corporal fibrosis, penile veno-occlusive dysfunction, Dupuytren's disease nodules, vaginal fibrosis, clitoral fibrosis, female s... | 03/13/2012 |
| 8124621 | Substituted 1-amino-4-phenyl-dihydroisoquinolines, methods for the production thereof, use thereof as a medicament, and medicaments containing them The present invention relates to compounds useful in the prevention or treatment of various disorders such as acute or chronic renal failure, for impairments of biliary function, for respiratory impairments such as snoring or sleep apneas or for stroke, and pharmace... | 02/28/2012 |
| 8093266 | Rho kinase inhibitors Substituted amide and urea derivatives useful as inhibitors of Rho kinase are described, which inhibitors can be useful in the treatment of various disorders such as cardiovascular diseases, cancer, neurological diseases, renal diseases, bronchial asthma, erectile d... | 01/10/2012 |
| 8088793 | Certain chemical entities, compositions, and methods Chemical entities that modulate smooth muscle myosin and/or non-muscle myosin, pharmaceutical compositions and methods of treatment of diseases and conditions associated with smooth muscle myosin and/or non-muscle myosin are described. ... | 01/03/2012 |
| 8071619 | Injectable liquid formulation of paracetamol The invention relates to a novel injectable liquid formulation of paracetamol, comprising an aqueous solvent, a buffer agent with a pKa between 4.5 and 6.5, an isotonic agent and the dimer of paracetamol of formula (I), a method for preparation of said formulation a... | 12/06/2011 |
| 8034829 | 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof The present invention relates to 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives represented by general formula D, their pharmacologically acceptable salts thereof, and compositions containing such compounds. Methods for treating hyperproliferative... | 10/11/2011 |
| 8008323 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, su... | 08/30/2011 |
| 7998978 | Substituted 2-amino-fused heterocyclic compounds The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein: R1, R2, Z1, t, and ring A are as defined in the specification. The invention also relates to pharmaceutical... | 08/16/2011 |
| 7994192 | Substituted thienopyridone compounds with antibacterial activity Novel bicyclic heteroaromatic compounds are provided that are inhibitors of bacterial methionyl tRNA synthetase (MetRS). Compounds of the invention generally have a left hand side chroman group or left hand side tetrahydroquinoline group and a right hand side thieno... | 08/09/2011 |
| 7994193 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, su... | 08/09/2011 |
| 7973052 | Compounds for the treatment of metabolic disorders Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. wher... | 07/05/2011 |
| 7943638 | Carboxamide compound and use of the same A carboxamide compound represented by the formula (1): [wherein Q represents a nitrogen-containing 6-membered aromatic heterocyclic group optionally fused with a benzene ring, one of ring constitutional atoms o... | 05/17/2011 |
| 7902224 | Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators The present invention is directed to compounds of formula (I): wherein R represents a methyl or an ethyl group X represents N, C—H or C—CH3 when X represents C—H or C—CH | 03/08/2011 |
| 7888371 | Use of triazolopyrimidine derivatives as microbicides Use of compounds of the formula (I) in which R1, R2, R3 and R4 are as defined in the description for protecting engineered materials. ... | 02/15/2011 |
| 7888372 | Compositions and methods for modulating bone mineral deposition The key function of TNAP in bone is degradation of PPi to remove this mineralization inhibitor and provide free phosphate for apatite deposition. PC-1 is a direct antagonist of TNAP function. ANK also antagonizes TNAP-dependent matrix calcification. Specifically, th... | 02/15/2011 |
| 7875631 | Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1 r inhibitors Compounds of the formula (I): where R2, R5, R6 have the meanings as given in the description, and U, V and W, respectively, may be CR2′, CR4′ and CR6′, respectively (with the definitions of R2′, R4′ and R6′ again as in the description), or may be N, were... | 01/25/2011 |
| 7863292 | Nitrogen-containing heteroaryl compounds and methods of use thereof The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo. ... | 01/04/2011 |
| 7790744 | Cyclic peptide antifungal agents and process for preparation thereof Provided are compounds of the formula (1): wherein R′ is hydrogen, methyl or NH2C(O)CH2—; R″ and R′″ are independently methyl or hydrogen; ... | 09/07/2010 |
| 7790745 | Tetrahydroisoquinoline LXR Modulators A compound of formula I wherein X, R1, R2a, R3a, R3b, R4a, R4b, R4c and R5 are defined herein. ... | 09/07/2010 |
| 7763638 | Substituted 1,2,3,4-tetrahydroisoquinoline derivatives The invention relates to novel 1,2,3,4-tetrahydroisoquinoline derivatives and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pha... | 07/27/2010 |
| 7750024 | Remedy for glioblastoma It is an object of the present invention to provide a novel therapeutic agent for glioblastoma. In accordance with the present invention, it was found that compounds having an antagonistic action against AMPA receptor are useful as therapeutic agents for glio... | 07/06/2010 |
| 7732462 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, su... | 06/08/2010 |
| 7728005 | Ether derivative The present invention relates to an ether derivative represented by the formula (I), a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof wherein each symbol is as defined in the description, a... | 06/01/2010 |
| 7713995 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, su... | 05/11/2010 |
| 7659285 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, su... | 02/09/2010 |
| 7645772 | Treatment of metabolic disorders Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed. ... | 01/12/2010 |
| 7629358 | Compounds useful for the treatment of diseases The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the ... | 12/08/2009 |
| 7615564 | Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same An objective of the present invention is to provide compounds having Rho kinase inhibitory activity and useful for the treatment of diseases mediated by Rho kinase. The compounds according to the present invention are those represented by formula (I) or pharmaceutic... | 11/10/2009 |
| 7615565 | VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. Th... | 11/10/2009 |
| 7601740 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases Behavioral pharmacological data with the compound of formula (I), a novel and selective 5HT2A/2C receptor inverse agonist, demonstrate in vivo efficacy in models of psychosis and dyskinesias. This includes activity in reversing MK-801 induced locomotor behaviors, su... | 10/13/2009 |
| 7589105 | Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound Pharmaceutical compositions and methods of treatment are provided for treating amyloidosis, containing, as an active ingredient, at least one nitrogen-containing heteroaryl compound represented by the following general formula or a pharmacologically permitted salt t... | 09/15/2009 |
| 7538121 | Vanilloid receptor modulators Certain compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein R1, R2, R3, P, X, Y, q, r ans s are as defined in the specification, a process for prepari... | 05/26/2009 |
| 7528151 | Heterocyclic urea derivatives for the treatment of pain Compounds of formula (I): or a pharmaceutically acceptable salt thereof, or a solvate thereof, wherein: P, P′, R1, R2, n, p, q, r, and s are as defined in the specification, processes for preparing s... | 05/05/2009 |
| 7528150 | Urea derivatives having vanilloid receptor antagonist activity According to the invention there are provided compounds of formula (I) wherein R1, p, P, n, s, r, W, P′, t, R2 and q are as defined in the specification, processes for preparing them and their use in... | 05/05/2009 |
| 7507748 | Substituted aryl-amine derivatives and methods of use Selected amines are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds of Formula I and II wherein R, R1 and R2 for e... | 03/24/2009 |
| 7495011 | Anti-coronavirus drug The present invention provides an anti-coronavirus agent including as an active ingredient as exemplified by nelfinavir and salts thereof, an anti-SARS agent including the anti-coronavirus agent, and a method of treating SARS using the anti-SARS agent. ... | 02/24/2009 |
| 7482361 | Crystalline form for quinapril hydrochloride and process for preparing the same A novel crystalline form of quinapril hydrochloride of formula (I) An amorphous form of quinapril hydrochloride substantially free of impurities, specially diketopiperazine compound, and conforming to pharmacopoeial specifica... | 01/27/2009 |
| 7456195 | Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants The present invention provides novel phenylglycinamide derivatives of Formula (I) or (IV): or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate, or prodrug thereof, wherein the variables W, W1, ... | 11/25/2008 |
